跳至主要内容
临床试验/ISRCTN26993825
ISRCTN26993825进行中(未招募)未知

Palliative long-term abdominal drains versus repeated drainage in untreatable ascites due to advanced cirrhosis: A randomised controlled trial (REDUCe 2 study)

niversity of Sussex0 个研究点目标入组 310 人开始时间: 2022年8月15日最近更新:

试验速览

阶段
未知
状态
进行中(未招募)
发起方
入组人数
310

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

性别
All

入选标准

  • Current participant inclusion criteria as of 01/11/2023:
  • Patient inclusion criteria:
  • 1. Aged 18 years old and over
  • 2. Refractory ascites due to cirrhosis (with the need for one or more LVP per month), defined as per International Ascites Club criteria (5-6):
  • 3. Diuretic-resistant ascites: ascites that cannot be mobilized or the early recurrence of which cannot be prevented because of a lack of response to sodium restriction and diuretic treatment (spironolactone 400 mg and furosemide 160 mg) and or Diuretic-intractable ascites: ascites that cannot be mobilized or the early recurrence of which cannot be prevented because of the development of diuretic-induced complications that preclude the use of an effective diuretic dosage
  • 4. Registered with a GP in the community Trusts served by the participating centres.
  • Previous participant inclusion criteria:
  • Patient inclusion criteria:
  • 1. Aged 18 years old and over
  • 2. Refractory ascites (with the need for one or more LVP per month), defined as per International Ascites Club criteria (5-6):
  • 3. Diuretic-resistant ascites: ascites that cannot be mobilized or the early recurrence of which cannot be prevented because of a lack of response to sodium restriction and diuretic treatment (spironolactone 400 mg and furosemide 160 mg) and or Diuretic-intractable ascites: ascites that cannot be mobilized or the early recurrence of which cannot be prevented because of the development of diuretic-induced complications that preclude the use of an effective diuretic dosage
  • 4. Registered with a GP in the community Trusts served by the participating centres.

排除标准

  • Patient exclusion criteria:
  • 1. Loculated and or chylous ascites
  • 2. Evidence of active infection that in the investigator’s opinion would preclude insertion of LTAD (for example, bacterial peritonitis) – such patients would need to receive appropriate treatment and could then be reconsidered
  • 3. A candidate for liver transplantation and or TIPS
  • 4. Psychosocial issues which in the opinion of the medical team will preclude study participation
  • 5. Pregnancy - all women of childbearing age must have a negative pregnancy test

研究者

发起方
niversity of Sussex

相似试验